GMP "focus buy" on WEDWestaim Corporation FOCUS BUY
WED $4.59 Target: $6.70
WED continues to enhance commercial viability of its high potential subsidiaries
. WED reports Q2/05 financial results
. Nucryst continues to experience strong Acticoat sales
. Phase 2b trials for NPI 32101 expected to commence in H2/05
. iFire Technology about to commission pilot plant
. We believe risk/reward proposition remains very attractive
if i wasn't already fully loaded with stock i'd be buying with both hands this morning!